Why the study?
Resistant hypertension increases cardiovascular event risk, but only one-fourth of patients with systolic BP above 160 mm Hg receive recommended screening for secondary causes, displaying a major gap in care.
Does a multidisciplinary program improve screening for secondary causes and blood pressure control in patients with resistant hypertension?
Does a multidisciplinary program improve screening for secondary causes and blood pressure control in patients with resistant hypertension?
A multidisciplinary program for resistant hypertension significantly improves screening for secondary causes and achieves blood pressure control in the majority of patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Martinez-Puente et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: